|Study Description:||The goal of this clinical research study is to learn if it is feasible to give |
a beta-blocker such as Inderal (propranolol hydrochloride) with standard
chemotherapy (paclitaxel and carboplatin or possibly docetaxel) to treat
ovarian cancer. The safety of propranolol hydrochloride will also be studied.
Propranolol hydrochloride is designed to block certain chemicals that affect
the heart. Researchers want to learn if this might also boost the immune
system, allowing the chemotherapy to be more effective.
Paclitaxel is designed to block cancer cells from dividing, which may cause
them to die.
Carboplatin is designed to interfere with the growth of cancer cells by
stopping cell division, which may cause the cells to die.